Company Number: 13214126

Analysis Date: 2025-07-29 15:54 UTC

1. Risk Rating: HIGH

This rating is driven primarily by significant liquidity concerns and a highly leveraged balance sheet, which pose material risks to the company’s ability to meet short-term obligations.

2. Key Concerns:

• Liquidity Deficit: The company shows consistently negative net current assets, worsening from -£60k (2023) to -£228k (2024), implying short-term liabilities significantly exceed current assets.
• High Current Liabilities: Current liabilities are very large (£1.028m in 2024) relative to cash and current assets, suggesting potential difficulties in meeting immediate debts without refinancing or asset sales.
• Leverage and Debt Profile: Creditors due after more than one year exceed £1m, indicating the company’s significant long-term indebtedness relative to net assets (£899k), which has also decreased year on year.

3. Positive Indicators:

• Substantial Fixed Assets: The company holds fixed assets valued at over £2.15m, which may provide collateral or value to support refinancing efforts.
• No Overdue Filings: Compliance with filing deadlines for accounts and confirmation statements is up to date, reducing regulatory risk.
• Stable Shareholders’ Funds: Despite net asset decline, shareholders’ funds remain positive and significant relative to the micro-entity scale, suggesting some retained equity cushion.

4. Due Diligence Notes:

• Cash Flow Analysis: Obtain detailed cash flow statements to assess operational cash generation and how the company plans to service its current liabilities.
• Debt Repayment Terms: Clarify the nature, maturity, and covenants of the long-term creditors (£1m+), including whether refinancing or restructuring is required.
• Fixed Asset Liquidity and Valuation: Verify the realizable value of the fixed assets (£2.15m) and their role in the business operations or debt security.
• Profitability and Revenue Trends: Since profit and loss data is not included, review management accounts or additional disclosures to understand operational sustainability.
• Director and PSC Backgrounds: Confirm there are no director disqualifications or compliance issues, noting Mrs. Dipali Patel is both director and significant controller.

Executive Summary
ARI PHARM LTD exhibits a precarious liquidity position with substantial current liabilities far exceeding current assets, raising concerns about short-term solvency. While the company holds significant fixed assets and complies with statutory filing requirements, the large debt burden and negative working capital highlight elevated financial risk. Further investigation into cash flow, debt structure, and asset valuation is essential to fully understand the company’s operational viability and financial resilience.